Literature DB >> 23834917

Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxin.

Yasushi Torii1, Miho Shinmura, Tomoko Kohda, Shunji Kozaki, Motohide Takahashi, Akihiro Ginnaga.   

Abstract

Botulinum type A antitoxin in standard and therapeutic preparation is a polyclonal antibody purified from immunized sera with subtype A1 toxin. To investigate the difference between immunological responses of antitoxin against toxin among different subtypes, we examined the response of polyclonal A1 and A2 antitoxins with A1 and A2 toxins. In the mouse neutralization test, the A1 antitoxin had equivalent potency against both the A1 and A2 toxins. However, the neutralization titer of the A2 antitoxin was 4-9 fold higher against the A2 toxin than against the A1 toxin. Since the titers of the antitoxins were calculated relative to the standard antitoxin, we assumed that the difference between the antibody titers against the test toxins was due the standard antitoxin having different reactivities with the toxins. The binding volume of the A2 toxin against the standard and A1 antitoxins was 3-4% of the binding volume of the A1 toxin. The neutralization curve of the standard antitoxin was parallel against both the A1 and A2 toxins. However, the curve of the A2 antitoxin was not parallel against the A1 and A2 toxins. Furthermore, binding analysis comparing these antitoxins and toxins showed that the A1 antitoxin had a higher binding affinity and slower dissociation speed with the A1 toxin than with the A2 toxin. In contrast, the A2 antitoxin showed a higher binding affinity with the A2 toxin than with the A1 toxin. These findings indicated that antitoxin reacted strongly against the same subtype, and showed a weak response against the toxin of different subtypes. We propose that the existing standard type A antitoxin should be used for reaction with A1 toxins, and that it is necessary to establish a new standard antitoxin for each subtype of toxin.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Botulinum antitoxin; Mouse neutralization test; Neutralization curves; Surface plasmon resonance; Toxin binding volume to antitoxin (L+ dose) measurement

Mesh:

Substances:

Year:  2013        PMID: 23834917     DOI: 10.1016/j.toxicon.2013.06.020

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.

Authors:  Skadi Kull; K Melanie Schulz; Jasmin Weisemann; Sebastian Kirchner; Tanja Schreiber; Alexander Bollenbach; P Wojtek Dabrowski; Andreas Nitsche; Suzanne R Kalb; Martin B Dorner; John R Barr; Andreas Rummel; Brigitte G Dorner
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 2.  Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature.

Authors:  Michael W Peck; Theresa J Smith; Fabrizio Anniballi; John W Austin; Luca Bano; Marite Bradshaw; Paula Cuervo; Luisa W Cheng; Yagmur Derman; Brigitte G Dorner; Audrey Fisher; Karen K Hill; Suzanne R Kalb; Hannu Korkeala; Miia Lindström; Florigio Lista; Carolina Lúquez; Christelle Mazuet; Marco Pirazzini; Michel R Popoff; Ornella Rossetto; Andreas Rummel; Dorothea Sesardic; Bal Ram Singh; Sandra C Stringer
Journal:  Toxins (Basel)       Date:  2017-01-18       Impact factor: 4.546

3.  Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins.

Authors:  Toshiaki Takeuchi; Tsuyoshi Okuno; Ai Miyashiro; Tomoko Kohda; Ryosuke Miyamoto; Yuishin Izumi; Shunji Kozaki; Ryuji Kaji
Journal:  Toxins (Basel)       Date:  2021-11-22       Impact factor: 4.546

4.  Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes.

Authors:  Christelle Mazuet; Christine Legeay; Jean Sautereau; Laurence Ma; Christiane Bouchier; Philippe Bouvet; Michel R Popoff
Journal:  Genome Biol Evol       Date:  2016-06-13       Impact factor: 3.416

5.  Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT).

Authors:  Lili Bai; Xiaobo Peng; Yanqing Liu; Yawei Sun; Xin Wang; Xingwang Wang; Guodong Lin; Peng Zhang; Kun Wan; Zewu Qiu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

Review 6.  Public Health Risk Associated with Botulism as Foodborne Zoonoses.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-12-30       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.